Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Calpain-10

The CAPN10 gene encodes calcium-dependent cysteine proteases. Mutations of the gene are associated with non-insulin-dependent diabetes mellitus 1 (NIDDM1).

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Noninsulin-dependent diabetes mellitus 1
CAPN10

References:

1.

Hanis CL et al. (1996) A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.

external link
2.

Carlsson E et al. (2004) Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.

external link
3.

Song Y et al. (2004) Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.

external link
4.

Gonzalez A et al. (2003) Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.

external link
5.

Weedon MN et al. (2003) Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.

external link
6.

Horikawa Y et al. (2003) Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese.

external link
7.

Gonzalez A et al. (2002) Comment: CAPN10 alleles are associated with polycystic ovary syndrome.

external link
8.

Hoffstedt J et al. (2002) Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells.

external link
9.

Ehrmann DA et al. (2002) Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.

external link
10.

Fullerton SM et al. (2002) Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus.

external link
11.

Elbein SC et al. (2002) Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians.

external link
12.

Tsai HJ et al. (2001) Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association.

external link
13.

Evans JC et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom.

external link
14.

Weiss KM et al. (2000) How many diseases does it take to map a gene with SNPs?

external link
15.

Kang ES et al. (2006) A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes.

external link
16.

None (2001) Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene.

external link
17.

Altshuler D et al. (2000) Guilt by association.

external link
18.

Horikawa Y et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.

external link
19.

NCBI article

NCBI 11132 external link
20.

OMIM.ORG article

Omim 605286 external link
21.

Wikipedia article

Wikipedia EN (CAPN10) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues